Release Date: 06/06/22 13:19 Summary: Units on Issue Disclosure - May 2022 Price Sensitive: No Download Document 116KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%